Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations.

This investigation facilitates a better understanding of inhibitor development, the critical treatment morbidity in HA patients. Furthermore, six novel mutations are reported, which would expand the mutation spectrum of the F8 gene.